Why Capital Access Isn’t the Same as Capital Leverage

Recent market dynamics reveal that uncertainty has been reshaping the definition of leverage. Banks continue to lend, and traditional lenders remain active, but inside those institutions, stress tests and risk committees have been recalibrating risk tolerance, driving tighter collateral thresholds on term loans and heightened utilization audits across existing credit lines, per Federal Reserve Survey SLOOS data from April 2025.

That tightening changes what a middle-market business can actually get funded against, even when capital itself is technically available. Traditional capital is still there to be had, but a business’s other real leverage, reputation, structural fit, embedded trust, often can’t be converted into funding. That’s because too many lenders still underwrite against only two things: how many assets can be pledged and what the cash flow projections say about repayment. Whatever doesn’t fit those two categories effectively doesn’t exist to that lender, even when it’s genuinely there.

As traditional lenders narrow access and evaluate performance against outdated models, we underwrite differently, using a framework we call the 5Cs of capital readiness: character, capacity, cash flow, collateral, and conditions. Each one gets its own read below, but together they let us determine what a growing business can actually rely on when its capital structure is tested under real uncertainty.

Leverage Is Not Borrowed Strength

There’s a version of leverage that most people default to without thinking much about it, how many assets can be pledged and what the cash flow projections say. It’s a useful shorthand, but an incomplete one, since it leaves out what a business has already built that a lender’s model was never designed to count.

We assess that fuller picture through a framework we call the 5Cs of capital readiness, used here to discern what a growing business can actually rely on when its capital structure is tested under real uncertainty.

Character covers the legacy, reputation, and leadership integrity of a business and its principals.

Capacity asks whether a business can absorb new capital and convert it into yield, both now and across its next phase of growth.

Cash flow asks whether there’s room for margins to grow with predictability and reliability over time.

Collateral asks what’s already pledged, what’s genuinely free, and what’s worth leveraging.

Conditions ask whether the use of funds is clean and aligned with how the capital structure is evolving.

In the two cases that follow, the Test of Character and the Test of Capacity, we look at what it means to deploy capital for structural alignment. In both, the business’s real leverage had nothing to do with what a senior lender’s model said, and everything to do with what these five categories actually revealed.

Case One: When Reputation Became the Bridge

• Client: A 55-year-old national food and snack manufacturer
• Challenge: Line of credit pulled after an inventory devaluation
• Capital event: An investment bank engaged to replace the senior lender, with board approval pending
• Key leverage: Operational continuity, contractual predictability, legacy credibility, and supply chain trust
• Capital deployed: $5 million term loan to preserve operational continuity and maintain vendor reputation

A national food and snack manufacturer, in business for 55 years, had built trusted vendor partnerships and a stable national retail base right up until 2025. That year, a year-long dip in the price of its core commodity, nuts, led its senior lender to reclassify the company’s risk profile and pull its line of credit entirely. That left the business with no interim breathing space and no bridge capital for the slow winter cycle ahead.

The company’s operations were unchanged, and its equity position remained stable, but a markdown on inventory value froze liquidity right as seasonal costs and vendor payments came due. The company’s investment banking partner was already working to secure a new senior lender, but board approval took time, and what the business needed most was an in-between solution, a junior position that preserved operations and trust without adding further distress.

Their investment banker saw what the situation actually called for, not a fresh appraisal, but a partner who could move on trust and structure, and brought in National. Together, we structured a $5 million term loan built to meet obligations, protect reputation, and honor agreements with farmers, distributors, drivers, retailers, and communities.

On paper, that inventory markdown looked like a straightforward loss, the kind of thing a lender reads as risk. The 5Cs told a different story, one where character functioned as capital in its own right. Underwriting rested on 55 years of supplier loyalty, especially among family-owned farms, and a consistent vendor payment record through prior downturns. It rested just as much on a brand reputation strong enough to keep shelves stocked at Costco, and on a clean use of funds backed by asset-based collateral with a credible path to recovery and a clear capital plan already underway with the investment bank.

That $5 million became part of the company’s interim capital plan. It gave the business time to finalize board approvals, gave the investment bank time to secure the senior facility, and gave the company time to unlock a deeper line of credit from its own ecosystem of farmers, because its reputation could carry real capital forward.

Case Two: When the Business had Already Changed and the Capital Hadn’t

• Client: A diagnostic lab-testing company with $80 million in annual revenue
• Challenge: Restructuring from a facility-dependent model to in-home testing services
• Capital event: An investment bank engaged to replace the senior lender as part of the broader restructuring
• Key leverage: Expanding services while maintaining operational profitability
• Capital deployed: $2 million term loan to retire junior debt and stabilize the capital structure

Healthcare is often filed under the “defensive sector,” which makes the operating strain inside many healthcare businesses easy to overlook. Delayed insurance reimbursements, regulatory lag, and staffing costs create chronic cash flow strain, and liquidity often comes at a premium unless a business is building independence from the insurance payment cycle. A diagnostic company generating $80 million a year in revenue had long operated on exactly that kind of facility-dependent model, carrying the weight of expensive equipment, onsite nursing staff, and reimbursement timelines that consistently ran behind the cost of running the business.

Two years ago, the company engaged an investment banking partner to restructure toward resilience, transitioning the model to include in-home testing services. The shift captured demand among seniors, homebound patients, immune-challenged individuals, and rural communities. Insurance payment timelines shortened, margins improved, and profitability became consistent for the first time in years.

But while the business model had modernized, the cap stack hadn’t kept pace. The senior lender remained anchored to the company’s past risk profile, penalizing what was now a profitable, streamlined business with outdated, short-term, high-interest debt that chipped away at its margin.

National had supported the junior layer through the two-year transition alongside the investment bank, watching the turnaround take shape from the inside. When the business reached the threshold for a full recapitalization, the investment bank selected our team to anchor the junior position, trusting National to serve as the bridge to a new senior lender and provide the stability needed to replace the legacy facility. Working within the investment bank’s mandate, we structured a $2 million term loan to retire the high-cost obligations, consolidate the junior layer, and present a clean foundation to the incoming senior lender.

That $2 million became a linchpin in the larger restructuring, an alignment between past complexity and future capacity. The funding simply reflected what had already changed. In that reflection, the cap stack began to mirror the business itself, lighter, steadier, and ready for what lay ahead. Presented to senior lenders, it stood structurally sound and positioned to secure the most favorable terms.

What This Means for the Businesses in Your Pipeline

Both of these companies had capital access in the conventional sense, a line of credit and a legacy senior facility, until each stopped matching what the business had actually become. What restored their footing was a lender willing to underwrite what was genuinely load-bearing inside the business rather than what a stress-tested model assumed from the outside.

At National, we don’t expect a business to perform for us the way it would for a conventional lender. We ask what’s already load-bearing inside it, what strain is hiding underneath the story it tells about itself, and what’s mature enough for a lender to actually underwrite against. For dealmakers and advisors evaluating a middle-market company right now, those three questions are more useful than the usual ones about collateral and projections.

Leverage doesn’t disappear in a tighter market. It just gets harder for a conventional model to see, especially in the exact moments that matter most: a devaluation with nothing to do with operating strength, a business model that has outgrown old debt, a restructuring that hasn’t fully shown up in the numbers yet. A generic model reads those moments as risk. They’re often where a business’s real position is clearest.

None of this argues against traditional lending discipline. Collateral and cash flow projections still do real underwriting work. The point is narrower. Those measures were never meant to be the whole picture, and treating them as though they were leaves real, provable strength off the table precisely when a business needs it recognized. A 55-year vendor relationship is a form of creditworthiness a bank statement doesn’t list, and it can carry real weight in an underwriting decision. A restructured operating model with margins better than the debt priced against it is a fact a lender can underwrite to in its own right.

For a business owner or advisor sitting across the table from a capital partner, that reframes the preparation question, from what can we pledge to what has this business already earned the right to lean on, and whether that can be made legible to the people deciding whether to fund it. The businesses that can answer that clearly tend to be the ones who find leverage even where a conventional model would miss it.

Joe Camberato is the CEO and founder of National Business Capital, a private lender helping businesses secure the capital they need to grow, scale, and move faster. Since 2007, Joe and his team have completed thousands of transactions, helping companies access over $3 billion in funding. Today, they’re the market leader in $150K to $15 million transactions, working with businesses that need speed, flexibility, and a reliable partner.

This article is sponsored by National Business Capital.

ACG Insights is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.